What are genome-wide association studies telling us about B-cell tumor development?
2010

Genome-wide association studies and B-cell tumor development

publication Evidence: moderate

Author Information

Author(s): Amy L. Sherborne, Richard S. Houlston

Primary Institution: Institute of Cancer Research

Hypothesis

Common genetic variation influences the development of B-cell malignancy.

Conclusion

Genome-wide association studies have identified several genetic loci that contribute to the risk of developing chronic lymphocytic leukemia and acute lymphoblastic leukemia.

Supporting Evidence

  • Genome-wide association studies have identified 10 novel risk loci for chronic lymphocytic leukemia.
  • Four risk loci for acute lymphoblastic leukemia were also identified.
  • Common genetic variations can significantly influence the risk of developing these blood cancers.

Takeaway

Scientists found that certain genes can make people more likely to get specific types of blood cancer. This helps us understand how these cancers develop.

Methodology

The study used a two-stage genome-wide association approach comparing SNP genotypes in cases and controls.

Limitations

The identified risk alleles account for less than 10% of the familial risk of CLL, indicating that many more variants likely remain to be discovered.

Statistical Information

P-Value

1.0x10−7

Statistical Significance

p<1.0x10−7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication